logoOmicsDI
  • Browse
  • Submit Data
  • Databases
  • API

4 Results

Show all   Save search   Copy query

Show results for

  • UnknownUnknown (4)

Publication Date

Release Date

  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
UnknownEfficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo-Controlled, Phase 3 Study.
Not available
S-EPMC11782106 | biostudies-literature
UnknownEfficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study.
Not available
S-EPMC6251842 | biostudies-literature
UnknownA randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis.
Not available
S-EPMC12672812 | biostudies-literature
UnknownEfficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis.
Not available
S-EPMC11499533 | biostudies-literature
  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
OmicsDI is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

EMBL-EBI logoEMBL-EBI logo

OmicsDI Databases

  • PRIDE
  • PeptideAtlas
  • MassIVE
  • JPOST Repository
  • Physiome Model Repository
  • EGA
  • EVA
  • ENA
  • LINCS
  • PAXDB
  • Cell Collective
  • MetaboLights
  • Metabolomics Workbench
  • MetabolomeExpress
  • GNPS
  • BioModels
  • FAIRDOMHub
  • ArrayExpress
  • dbGaP
  • ExpressionAtlas
  • GEO
  • NODE

Information

  • Databases
  • Help
  • API
  • Contact us
  • Code on GitHub
  • Terms of use
  • Submit Data